Therapeutic potential of Bcl-xL/Mcl-1 synthetic inhibitor JY-1-106 and retinoids for human triple-negative breast cancer treatment.
about
Therapeutic potential of Bcl-xL/Mcl-1 synthetic inhibitor JY-1-106 and retinoids for human triple-negative breast cancer treatment.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Therapeutic potential of Bcl-x ...... ative breast cancer treatment.
@en
Therapeutic potential of Bcl-x ...... ative breast cancer treatment.
@nl
type
label
Therapeutic potential of Bcl-x ...... ative breast cancer treatment.
@en
Therapeutic potential of Bcl-x ...... ative breast cancer treatment.
@nl
prefLabel
Therapeutic potential of Bcl-x ...... ative breast cancer treatment.
@en
Therapeutic potential of Bcl-x ...... ative breast cancer treatment.
@nl
P2093
P2860
P356
P1433
P1476
Therapeutic potential of Bcl-x ...... ative breast cancer treatment.
@en
P2093
Erika Cione
Jeremy L Yap
Mariarita Perri
Maureen A Kane
Steven Fletcher
P2860
P304
P356
10.3892/OL.2018.8258
P577
2018-03-14T00:00:00Z